Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study aims to help Native Hawaiian adults quit smoking by testing two common methods: nicotine gum and group-based counseling. Participants will be assigned to one of three groups: (1) nicotine gum only, (2) group counseling only, or (3) a combination of both. The study will take place at public housing sites on O'ahu. Researchers will check if these approaches-alone or in combination-can support people in successfully quitting smoking. The goal is to find out which method works best and is most acceptable in this community.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| NRT Gum Only | Experimental | Participants receive nicotine gum (2 mg) according to a 12-week FDA-approved tapering schedule. No counseling is provided. |
|
| CBGT Only | Experimental | Participants attend six weekly sessions of cognitive-behavioral group therapy (CBGT) for smoking cessation. No nicotine gum is provided. |
|
| CBGT + NRT Gum | Experimental | Participants receive both nicotine gum (2 mg, tapered over 12 weeks) and attend six weekly CBGT sessions for smoking cessation. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Nicotine Polacrilex Gum (2 mg) | Drug | Participants chew 2 mg nicotine gum according to a tapering 12-week schedule: Weeks 1-6: 1 piece every 1-2 hours; at least 9 pieces/day; Weeks 7-9: 1 piece every 2-4 hours; Weeks 10-12: 1 piece every 4-8 hours. Max 24 pieces/day. Gum is distributed every 2 weeks during study visits. Arm(s) Used In: NRT Gum Only CBGT + NRT Gum |
| Measure | Description | Time Frame |
|---|---|---|
| 7-day point prevalence abstinence (PPA) | Self-reported 7-day point prevalence abstinence from cigarette smoking, confirmed by exhaled carbon monoxide (eCO) <10 ppm at final follow-up visit. | 12 weeks after baseline (Study Visit 8) |
| Measure | Description | Time Frame |
|---|---|---|
| Change in nicotine dependence | Change in nicotine dependence scores as measured by standardized tools (e.g., Fagerström Test for Nicotine Dependence). | Baseline to 12 weeks |
| Change in smoking self-efficacy |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Pallav Pokhrel, PhD, MPH | Contact | 808-441-7711 | ppokhrel@cc.hawaii.edu | |
| Yoko Takahashi, MD | Contact | 8086926501 | ytakahashi@cc.hawaii.edu |
| Name | Affiliation | Role |
|---|---|---|
| Crissy T Kawamoto | University of Hawai'i Cancer Center | Study Director |
| Pallav Pokhrel, PhD, MPH | University of Hawai'i Cancer Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Hawai'i | Honolulu | Hawaii | 96813 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 26092476 | Result | Whitehead AL, Julious SA, Cooper CL, Campbell MJ. Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable. Stat Methods Med Res. 2016 Jun;25(3):1057-73. doi: 10.1177/0962280215588241. Epub 2015 Jun 19. | |
| 20099947 | Result |
| Label | URL |
|---|---|
| General consumer information about nicotine gum, including proper use, precautions, and side effects. Provided by MedlinePlus, a service of the U.S. National Library of Medicine. | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D014029 | Tobacco Use Disorder |
| D016540 | Smoking Cessation |
| D000073865 | Cigarette Smoking |
| ID | Term |
|---|---|
| D019966 | Substance-Related Disorders |
| D064419 | Chemically-Induced Disorders |
| D001523 | Mental Disorders |
| D015438 | Health Behavior |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Cognitive Behavioral Group Therapy (CBGT) | Behavioral | Participants attend six sessions of group-based cognitive behavioral therapy focused on smoking cessation, over the 12-week study period. Sessions include education on cravings, relapse prevention, stress management, and self-efficacy building. Arm(s) Used In: CBGT Only CBGT + NRT Gum |
|
Change in participants' confidence in their ability to quit smoking, measured using a validated smoking self-efficacy scale.
| Baseline to 12 weeks |
| Number of adverse events | Frequency and severity of adverse events related to nicotine gum or study procedures, as reported by participants or observed by study staff. | Throughout the 12-week intervention period |
| Webb MS, de Ybarra DR, Baker EA, Reis IM, Carey MP. Cognitive-behavioral therapy to promote smoking cessation among African American smokers: a randomized clinical trial. J Consult Clin Psychol. 2010 Feb;78(1):24-33. doi: 10.1037/a0017669. |
| 28361497 | Result | Stead LF, Carroll AJ, Lancaster T. Group behaviour therapy programmes for smoking cessation. Cochrane Database Syst Rev. 2017 Mar 31;3(3):CD001007. doi: 10.1002/14651858.CD001007.pub3. |
| 27658756 | Result | Rohsenow DJ, Martin RA, Tidey JW, Colby SM, Monti PM. Treating Smokers in Substance Treatment With Contingent Vouchers, Nicotine Replacement and Brief Advice Adapted for Sobriety Settings. J Subst Abuse Treat. 2017 Jan;72:72-79. doi: 10.1016/j.jsat.2016.08.012. Epub 2016 Aug 18. |
| 18374742 | Result | Ong JC, Kuo TF, Manber R. Who is at risk for dropout from group cognitive-behavior therapy for insomnia? J Psychosom Res. 2008 Apr;64(4):419-25. doi: 10.1016/j.jpsychores.2007.10.009. |
| 10165099 | Result | Nevid JS, Javier RA. Preliminary investigation of a culturally specific smoking cessation intervention for Hispanic smokers. Am J Health Promot. 1997 Jan-Feb;11(3):198-207. doi: 10.4278/0890-1171-11.3.198. |
| 21414733 | Result | Meredith SE, Grabinski MJ, Dallery J. Internet-based group contingency management to promote abstinence from cigarette smoking: a feasibility study. Drug Alcohol Depend. 2011 Oct 1;118(1):23-30. doi: 10.1016/j.drugalcdep.2011.02.012. Epub 2011 Mar 16. |
| 30797382 | Result | Lo Coco G, Melchiori F, Oieni V, Infurna MR, Strauss B, Schwartze D, Rosendahl J, Gullo S. Group treatment for substance use disorder in adults: A systematic review and meta-analysis of randomized-controlled trials. J Subst Abuse Treat. 2019 Apr;99:104-116. doi: 10.1016/j.jsat.2019.01.016. Epub 2019 Jan 24. |
| 27699443 | Result | Lee PN, Fariss MW. A systematic review of possible serious adverse health effects of nicotine replacement therapy. Arch Toxicol. 2017 Apr;91(4):1565-1594. doi: 10.1007/s00204-016-1856-y. Epub 2016 Oct 3. |
| 28361496 | Result | Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev. 2017 Mar 31;3(3):CD001292. doi: 10.1002/14651858.CD001292.pub3. |
| 33853658 | Result | Hunt DF, Bailey J, Lennox BR, Crofts M, Vincent C. Enhancing psychological safety in mental health services. Int J Ment Health Syst. 2021 Apr 14;15(1):33. doi: 10.1186/s13033-021-00439-1. |
| 23954946 | Result | Hiscock R, Murray S, Brose LS, McEwen A, Bee JL, Dobbie F, Bauld L. Behavioural therapy for smoking cessation: the effectiveness of different intervention types for disadvantaged and affluent smokers. Addict Behav. 2013 Nov;38(11):2787-96. doi: 10.1016/j.addbeh.2013.07.010. Epub 2013 Jul 21. |
| 29137909 | Result | Goldstein AO, Gans SP, Ripley-Moffitt C, Kotsen C, Bars M. Use of Expired Air Carbon Monoxide Testing in Clinical Tobacco Treatment Settings. Chest. 2018 Feb;153(2):554-562. doi: 10.1016/j.chest.2017.11.002. Epub 2017 Nov 11. |
| 22035998 | Result | Gifford EV, Kohlenberg BS, Hayes SC, Pierson HM, Piasecki MP, Antonuccio DO, Palm KM. Does acceptance and relationship focused behavior therapy contribute to bupropion outcomes? A randomized controlled trial of functional analytic psychotherapy and acceptance and commitment therapy for smoking cessation. Behav Ther. 2011 Dec;42(4):700-15. doi: 10.1016/j.beth.2011.03.002. Epub 2011 May 25. |
| 31725711 | Result | Creamer MR, Wang TW, Babb S, Cullen KA, Day H, Willis G, Jamal A, Neff L. Tobacco Product Use and Cessation Indicators Among Adults - United States, 2018. MMWR Morb Mortal Wkly Rep. 2019 Nov 15;68(45):1013-1019. doi: 10.15585/mmwr.mm6845a2. |
| 15796782 | Result | Carter RE, Sonne SC, Brady KT. Practical considerations for estimating clinical trial accrual periods: application to a multi-center effectiveness study. BMC Med Res Methodol. 2005 Mar 30;5:11. doi: 10.1186/1471-2288-5-11. |
| 28056007 | Result | Babb S, Malarcher A, Schauer G, Asman K, Jamal A. Quitting Smoking Among Adults - United States, 2000-2015. MMWR Morb Mortal Wkly Rep. 2017 Jan 6;65(52):1457-1464. doi: 10.15585/mmwr.mm6552a1. |
| Strategic plan from the Hawai'i State Department of Health outlining goals and priorities for tobacco prevention and control across the state, including culturally tailored interventions for Native Hawaiians and other priority populations. | View source |
| Behavioral Risk Factor Surveillance System (BRFSS) data from the Hawai'i Health Data Warehouse showing smoking prevalence among adults by race/ethnicity from 2018-2023. Useful for understanding disparities in tobacco use among Native Hawaiians and other | View source |
| Summary report from the Hawai'i Tumor Registry presenting cancer incidence and mortality data in Hawai'i from 2014-2018. Includes statistics by race/ethnicity and geographic region, supporting local relevance of tobacco-related cancer prevention. | View source |
| ICH E2A guideline outlining international standards for defining, collecting, and reporting clinical safety data, including serious adverse events (SAEs) and expedited reporting procedures. | View source |
| Guidelines from the National Cancer Institute (NCI) detailing adverse event reporting requirements for investigators conducting studies under NCI's Division of Cancer Treatment and Diagnosis (DCTD) and Division of Cancer Prevention (DCP) INDs and IDEs. | View source |
| Official NCI Thesaurus entry for "Nicotine Dependence," providing standardized terminology and coding used in biomedical research and clinical trial reporting. | View source |
| National Cancer Institute fact sheet offering practical guidance for managing nicotine withdrawal symptoms and behavioral triggers when quitting tobacco. Intended for patients and healthcare providers. | View source |
| The 2014 Surgeon General's Report summarizes 50 years of scientific evidence on the health effects of smoking. It provides comprehensive data on smoking-related diseases, tobacco use patterns, and public health impact in the U.S. | View source |
| D001519 | Behavior |
| D000073869 | Tobacco Smoking |
| D012907 | Smoking |
| D064424 | Tobacco Use |